TrkB-Targeted Therapy for Mucoepidermoid Carcinoma.

Biomedicines · 2020 · PMC7759804 · PMID 33255325

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

Differences in TrkB immunohistochemical levels among MEC grades did not achieve significance, but this was probably due to the small number of high-grade cases studied.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.